Serum AMH, FSH, and LH levels in PCOS

Fertility and Sterility

Volumn 93, Issue 3, 2010, Pages

  Georgopoulos, Neoklis A ^a   Saltamavros, Alexandros D ^a   Decavalas, George ^a   Piouka, Athanasia ^b   Katsikis, Ilias ^b   Panidis, Dimitrios ^b  

^a UNIVERSITY OF PATRAS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR;

BODY MASS; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; LETTER; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HORMONES; HUMANS; LUTEINIZING HORMONE; POLYCYSTIC OVARY SYNDROME; PREDICTIVE VALUE OF TESTS;

EID: 75849137699     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.10.006     Document Type: Letter

References (3)

1. Singer T., Barad D.H., Weghofer A., and Gleicher N. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels. Fertil Steril 91 (2009) 2616-2619
2. Dumesic D.A., Lesnick T.G., Stassart J.P., Ball G.D., Wong A., and Abbott D.H. Intrafollicular antimullerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer. Fertil Steril 92 (2009) 217-221
3. Piouka A., Farmakiotis D., Katsikis I., Macut D., Gerou S., and Panidis D. Anti-müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab 296 (2009) E238-E243